amlodipine has been researched along with Prostatic Hyperplasia in 4 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This prospective randomized double-blinded clinical trial was designed to explore the effects of amlodipine and the combination of amlodipine with terazosin in improving postvoid residual (PVR) in patients with lower urinary tract symptoms (LUTS) and concomitant hypertension." | 9.14 | [Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention]. ( Fang, J; Li, YL; Liu, HP; Qin, XH; Xu, XP; Yang, C; Zhang, X, 2009) |
| "To investigate the effects of amlodipine, a dihydropyridine calcium-channel blocker, alone or combined with terazosin, on urodynamics in rats with benign prostatic hyperplasia (BPH) and in female rats with detrusor instability (DI)." | 7.75 | Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity. ( Chen, GL; Liu, HP; Liu, P; Xu, XP, 2009) |
| "This prospective randomized double-blinded clinical trial was designed to explore the effects of amlodipine and the combination of amlodipine with terazosin in improving postvoid residual (PVR) in patients with lower urinary tract symptoms (LUTS) and concomitant hypertension." | 5.14 | [Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention]. ( Fang, J; Li, YL; Liu, HP; Qin, XH; Xu, XP; Yang, C; Zhang, X, 2009) |
| "To investigate the effects of amlodipine, a dihydropyridine calcium-channel blocker, alone or combined with terazosin, on urodynamics in rats with benign prostatic hyperplasia (BPH) and in female rats with detrusor instability (DI)." | 3.75 | Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity. ( Chen, GL; Liu, HP; Liu, P; Xu, XP, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marzabadi, MR | 1 |
| Hong, X | 1 |
| Nagarathnam, D | 1 |
| Miao, SW | 1 |
| Chiu, G | 1 |
| Wong, WC | 1 |
| Wetzel, JM | 1 |
| Fang, J | 2 |
| Forray, C | 1 |
| Chen, TB | 1 |
| O'Malley, SS | 1 |
| Chang, RS | 1 |
| Gluchowski, C | 1 |
| Liu, HP | 2 |
| Chen, GL | 1 |
| Liu, P | 1 |
| Xu, XP | 2 |
| Yang, C | 1 |
| Li, YL | 1 |
| Zhang, X | 1 |
| Qin, XH | 1 |
| Belavic, JM | 1 |
1 trial available for amlodipine and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention].
Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Antihypertensive Agents; Double-Blind Method; Drug T | 2009 |
3 other studies available for amlodipine and Prostatic Hyperplasia
| Article | Year |
|---|---|
Design and synthesis of novel dihydropyridine alpha-1a antagonists.
Topics: Adrenergic Antagonists; Animals; Calcium Channels; Dihydropyridines; Dogs; Humans; Male; Molecular S | 1999 |
Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity.
Topics: Adrenergic alpha-Antagonists; Amlodipine; Animals; Calcium Channel Blockers; Drug Therapy, Combinati | 2009 |
Annual drug update: 2010 in review.
Topics: Amlodipine; Antihypertensive Agents; Azasteroids; Clindamycin; Dermatologic Agents; Drug Combination | 2011 |